The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8999957, Table 2, Compound 62 ID: ALA3654536
Chembl Id: CHEMBL3654536
PubChem CID: 89509226
Max Phase: Preclinical
Molecular Formula: C29H29FN6O3
Molecular Weight: 528.59
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(F)c1CN1CC(CO)CC(NC(=O)c2ccc3[nH]nc(-c4ccc5nccn5c4)c3c2)C1
Standard InChI: InChI=1S/C29H29FN6O3/c1-39-26-4-2-3-24(30)23(26)16-35-13-18(17-37)11-21(15-35)32-29(38)19-5-7-25-22(12-19)28(34-33-25)20-6-8-27-31-9-10-36(27)14-20/h2-10,12,14,18,21,37H,11,13,15-17H2,1H3,(H,32,38)(H,33,34)
Standard InChI Key: FTYRIDBXVJYNEG-UHFFFAOYSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 528.59Molecular Weight (Monoisotopic): 528.2285AlogP: 3.64#Rotatable Bonds: 7Polar Surface Area: 107.78Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.07CX Basic pKa: 6.65CX LogP: 2.35CX LogD: 2.28Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.30Np Likeness Score: -1.47
References 1. (2015) Heterocyclic compounds as ERK inhibitors,